Eurofins · 3 months ago
Bioassay Analyst
Eurofins is an international life sciences company providing analytical testing services to ensure product safety and authenticity. The Bioassay Analyst will perform cell-based and surrogate bioassays in a GMP environment, document laboratory work, and communicate results through electronic systems.
BiotechnologyGeneticsHealth CareLife SciencePharmaceutical
Responsibilities
Perform cell-based bioassays and surrogate bioassays such as ligand-binding ELISA assays in plate-based format in a GMP environment
Perform qualification and transfer of analytical test methods in the GMP environment
Document laboratory work in notebooks/electronic notebooks and log books, perform data integrity checks, data verification reviews, and communicate final results through electronic systems
Qualification
Required
Bachelor's degree in life science concentration (chemistry, biology, or related fields) and 2 to 4 years of directly related industry experience or a MS degree in a life science concentration (chemistry, biology, or related fields) and up to 2 years of directly related industry experience
Strong computer, scientific, and organizational skills
Experience with reporter-gene assay, cell biology skills such as cell culturing, cell counting, cell banking; GMP quality system and lab operations experience
Excellent communication (oral and written) and attention to detail
Ability to work independently and as part of a team with internal and external clients, self‑motivation, adaptability, and a positive attitude
Ability to learn new techniques, keep accurate records, follow instructions, and comply with company policies
Authorization to work in the United States indefinitely without restriction or sponsorship
Benefits
Excellent full-time benefits including comprehensive medical coverage, dental, and vision options
Life and disability insurance
401(k) with company match
Paid vacation and holidays
Company
Eurofins
Eurofins provides testing and support services to the pharmaceutical, food, environmental, and consumer products industries.
Funding
Current Stage
Public CompanyTotal Funding
$1.05B2025-06-26Post Ipo Debt· $586.37M
2025-03-27Post Ipo Debt· $431.4M
2021-10-22Grant· $30M
Recent News
2025-12-16
Business Wire
2025-12-08
Company data provided by crunchbase